|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
138,800,000 |
Market
Cap: |
1.07(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$4.7 - $15 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Maravai is a holding company. Through its subsidiaries, Co. operates as a life sciences company that provides products to enable the development of drug, therapies, diagnostics, vaccines, and support research on human diseases. Co. operates in two segments: Nucleic Acid Production, which includes messenger ribonucleic acid, long and short oligonucleotides, its CleanCap® capping technology and oligonucleotide building blocks; and Biologics Safety Testing, which sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Burch Andrew |
See Remarks |
|
2024-04-15 |
4 |
D |
$8.11 |
$135,907 |
D/D |
(16,758) |
420,035 |
|
- |
|
Dolan Christine |
See Remarks |
|
2024-03-15 |
4 |
D |
$7.70 |
$41,449 |
D/D |
(5,383) |
258,007 |
|
- |
|
Buzzeo Rebecca |
See Remarks |
|
2024-03-15 |
4 |
D |
$7.70 |
$33,618 |
D/D |
(4,366) |
365,066 |
|
- |
|
Hull Carl |
See Remarks |
|
2024-03-15 |
4 |
D |
$7.70 |
$135,212 |
D/D |
(17,560) |
267,072 |
|
- |
|
Leddy Peter Michael |
See Remarks |
|
2024-03-15 |
4 |
D |
$7.70 |
$51,698 |
D/D |
(6,714) |
376,359 |
|
- |
|
Herde Kevin |
Chief Financial Officer |
|
2024-03-15 |
4 |
D |
$7.70 |
$66,405 |
D/D |
(8,624) |
332,914 |
|
- |
|
Oreshack Kurt |
General Counsel |
|
2024-03-15 |
4 |
D |
$7.70 |
$35,043 |
D/D |
(4,551) |
223,349 |
|
- |
|
Oreshack Kurt |
General Counsel |
|
2024-02-15 |
4 |
D |
$5.48 |
$12,725 |
D/D |
(2,322) |
227,900 |
|
- |
|
Herde Kevin |
Chief Financial Officer |
|
2024-02-15 |
4 |
D |
$5.48 |
$14,599 |
D/D |
(2,664) |
341,538 |
|
- |
|
Dolan Christine |
See Remarks |
|
2024-02-15 |
4 |
D |
$5.48 |
$10,637 |
D/D |
(1,941) |
263,390 |
|
- |
|
Hull Carl |
See Remarks |
|
2024-02-15 |
4 |
D |
$5.48 |
$58,795 |
D/D |
(10,729) |
284,632 |
|
- |
|
Herde Kevin |
Chief Financial Officer |
|
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
250,277 |
344,202 |
|
- |
|
Martin William E. Iii |
Chief Executive Officer |
|
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
758,415 |
1,040,273 |
|
- |
|
Buzzeo Rebecca |
See Remarks |
|
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
288,198 |
369,432 |
|
- |
|
Dolan Christine |
See Remarks |
|
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
189,604 |
265,331 |
|
- |
|
Leddy Peter Michael |
See Remarks |
|
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
250,277 |
383,073 |
|
- |
|
Burch Andrew |
See Remarks |
|
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
295,782 |
436,793 |
|
- |
|
Oreshack Kurt |
General Counsel |
|
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
166,852 |
230,222 |
|
- |
|
Hull Carl |
See Remarks |
|
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
75,842 |
295,361 |
|
- |
|
Buzzeo Rebecca |
See Remarks |
|
2023-11-15 |
4 |
D |
$5.19 |
$23,609 |
D/D |
(4,549) |
81,234 |
|
- |
|
Herde Kevin |
Chief Financial Officer |
|
2023-10-31 |
4 |
A |
$5.83 |
$10,850 |
D/D |
1,861 |
93,925 |
|
- |
|
Dolan Christine |
See Remarks |
|
2023-10-31 |
4 |
A |
$5.83 |
$10,080 |
D/D |
1,729 |
75,727 |
|
- |
|
Leddy Peter Michael |
See Remarks |
|
2023-10-31 |
4 |
A |
$5.83 |
$2,618 |
D/D |
449 |
132,796 |
|
- |
|
Martin William E. Iii |
Chief Executive Officer |
|
2023-10-16 |
4 |
D |
$7.54 |
$499,125 |
D/D |
(66,197) |
281,858 |
|
- |
|
Deford John A |
Director |
|
2023-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
31,901 |
31,901 |
|
- |
|
102 Records found
|
|
Page 1 of 5 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|